| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.26 | 3e-06 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.16 | 0.003 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.1 | 0.06 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.092 | 0.07 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.097 | 0.08 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.091 | 0.1 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.07 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.072 | 0.2 |